Compare Novo Nordisk A/S (NVO) vs Wipro Limited (WIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Wipro Limited — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Wipro Limited trades at $1.87 (market cap $18.49B). The key difference: Novo Nordisk A/S is far larger — about 11.9× Wipro Limited's market cap, and Wipro Limited pays the higher dividend (4.68%). Which is the better fit depends on your goals.
| NVO | WIT | |
|---|---|---|
Market Cap | $220.53B | $18.49B |
Sector | Health | Technology |
52-Week High | $71.70 | $3.06 |
52-Week Low | $35.29 | $1.82 |
Enterprise Value | $239.49B | $16.42B |
Dividend Yield | 3.63% | 4.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Wipro Limited
Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →
